Mar 7 |
Evogene GAAP EPS of -$0.13 beats by $0.01, revenue of $0.58M misses by $0.31M
|
Mar 7 |
Evogene Reports Fourth Quarter and Full Year 2023 Financial Results
|
Mar 7 |
Earnings Scheduled For March 7, 2024
|
Mar 6 |
Evogene Q4 2023 Earnings Preview
|
Mar 6 |
AgPlenus Achieves Milestone in Collaboration with Corteva to Develop Novel Herbicides
|
Mar 1 |
Evogene files for $200M mixed shelf offering
|
Feb 28 |
Lavie Bio Successfully Secures Second Half Advance Payment of $2.5M after Meeting Corteva's Licensing Agreement Requirements
|
Feb 26 |
Evogene Schedules Fourth Quarter 2023 Financial Results Release & Conference Call for March 7th, 2024
|
Feb 21 |
AgPlenus Announces Licensing & Collaboration Agreement with Bayer to Develop a New Sustainable Weed Control Solution
|
Feb 20 |
Syngenta and Lavie Bio Announce Partnership to Discover and Develop Novel Bio-Insecticide
|